Literature DB >> 3307495

Serum procollagen type III N-terminal peptides and laminin P1 peptide in alcoholic liver disease.

T Nouchi, T M Worner, S Sato, C S Lieber.   

Abstract

The appearance of perivenular fibrosis on liver biopsy reflects the beginning of the fibrotic process that ultimately results in liver cirrhosis. To examine whether the fibrogenic activity can be detected by blood tests, we evaluated whole antibody radioimmunoassay (RIA) of procollagen type III N-terminal peptides (P-III-P), RIA of these peptides using Fab fragments (Fab-P-III-P), and RIA of the laminin P1 peptide in alcoholics within 1 week of alcohol abstinence. The Fab-P-III-P levels in subjects with perivenular fibrosis were significantly higher than those in patients with simple fatty liver. Values in 63% of subjects with perivenular fibrosis exceeded the upper limit of the fatty liver group. Patients with simple fatty liver had significantly lower values than nonalcoholic controls. Serum levels of P-III-P and laminin were elevated in patients with alcoholic hepatitis and correlated well with the degree of inflammation. With abstinence, Fab-P-III-P levels increased in all alcoholics. P-III-P values increased in patients with normal P-III-P values on admission. By contrast, the values of laminin decreased during abstinence. Therefore, to interpret serum levels of Fab-P-III-P, P-III-P, and laminin, the duration of abstinence must be taken into consideration. P-III-P, Fab-P-III-P and laminin measurements in the serum within 1 week of abstinence can contribute to the detection of alcoholic liver disease and the determination of its stage.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3307495     DOI: 10.1111/j.1530-0277.1987.tb01309.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  13 in total

Review 1.  Hepatic fibrosis: are any of the serum markers useful?

Authors:  S Oh; N H Afdhal
Journal:  Curr Gastroenterol Rep       Date:  2001-02

2.  Serum concentrations of laminin in cirrhosis of the liver.

Authors:  J Collazos; F Díaz; J Genollá
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

3.  Emodin protects rat liver from CCl(4)-induced fibrogenesis via inhibition of hepatic stellate cells activation.

Authors:  Miao-Xian Dong; Yan Jia; Ying-Bo Zhang; Cheng-Chong Li; Yu-Tao Geng; Li Zhou; Xue-Yan Li; Ji-Cheng Liu; Ying-Cai Niu
Journal:  World J Gastroenterol       Date:  2009-10-14       Impact factor: 5.742

4.  A rabbit model of pediatric nonalcoholic steatohepatitis: the role of adiponectin.

Authors:  Jun-Fen Fu; Yan-Lan Fang; Li Liang; Chun-Lin Wang; Fang Hong; Guan-Ping Dong
Journal:  World J Gastroenterol       Date:  2009-02-28       Impact factor: 5.742

5.  Serum type IV collagen level is predictive for esophageal varices in patients with severe alcoholic disease.

Authors:  Satoshi Mamori; Yasuyuki Searashi; Masato Matsushima; Kenichi Hashimoto; Shinichiro Uetake; Hiroshi Matsudaira; Shuji Ito; Hisato Nakajima; Hisao Tajiri
Journal:  World J Gastroenterol       Date:  2008-04-07       Impact factor: 5.742

6.  Study of serum procollagen type III peptide in patients with hepatic cirrhosis from a clinical point of view.

Authors:  F Díaz; J Collazos; J Genollá
Journal:  Clin Investig       Date:  1993-05

7.  Systematic review of the diagnostic performance of serum markers of liver fibrosis in alcoholic liver disease.

Authors:  Julie Parkes; Indra Neil Guha; Scott Harris; William Mc Rosenberg; Paul J Roderick
Journal:  Comp Hepatol       Date:  2012-12-28

8.  The restorative effect of taurine on experimental nonalcoholic steatohepatitis.

Authors:  Si-Wen Chen; Yue-Xiang Chen; Jian Shi; Yong Lin; Wei-Fen Xie
Journal:  Dig Dis Sci       Date:  2006-11-02       Impact factor: 3.487

9.  Serum laminin P1 in small cell lung cancer: a valuable indicator of distant metastasis?

Authors:  T Nakano; N Iwahashi; J Maeda; T Hada; K Higashino
Journal:  Br J Cancer       Date:  1992-04       Impact factor: 7.640

10.  Contribution of Cyclooxygenase End Products and Oxidative Stress to Intrahepatic Endothelial Dysfunction in Early Non-Alcoholic Fatty Liver Disease.

Authors:  Francisco Javier Gonzalez-Paredes; Goretti Hernández Mesa; Dalia Morales Arraez; Raquel Marcelino Reyes; Beatriz Abrante; Felicitas Diaz-Flores; Eduardo Salido; Enrique Quintero; Manuel Hernández-Guerra
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.